These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20404077)

  • 1. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.
    Propst KL; Mima T; Choi KH; Dow SW; Schweizer HP
    Infect Immun; 2010 Jul; 78(7):3136-43. PubMed ID: 20404077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.
    Norris MH; Rahman Khan MS; Schweizer HP; Tuanyok A
    BMC Microbiol; 2017 Jun; 17(1):132. PubMed ID: 28592242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.
    Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK
    PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
    Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.
    Gutierrez MG; Warawa JM
    Acta Trop; 2016 May; 157():68-72. PubMed ID: 26836271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
    Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
    Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LVS Δ
    Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
    Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
    Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence Factors.
    Chua J; Nguyenkhoa E; Mou S; Tobery SA; Friedlander AM; DeShazer D
    Infect Immun; 2022 Aug; 90(8):e0015922. PubMed ID: 35862734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei.
    Campos CG; Borst L; Cotter PA
    Infect Immun; 2013 Apr; 81(4):1121-8. PubMed ID: 23340315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.
    Ulett GC; Ketheesan N; Clair TW; McElnea CL; Barnes JL; Hirst RG
    Infect Immun; 2002 Jul; 70(7):3953-8. PubMed ID: 12065542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lesion formation in marmosets following inhalational challenge with different strains of Burkholderia pseudomallei.
    Nelson M; Nunez A; Ngugi SA; Sinclair A; Atkins TP
    Int J Exp Pathol; 2015 Dec; 96(6):414-26. PubMed ID: 26852689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.
    Welkos SL; Klimko CP; Kern SJ; Bearss JJ; Bozue JA; Bernhards RC; Trevino SR; Waag DM; Amemiya K; Worsham PL; Cote CK
    PLoS One; 2015; 10(4):e0124667. PubMed ID: 25909629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.
    Barnes JL; Ulett GC; Ketheesan N; Clair T; Summers PM; Hirst RG
    Immunol Cell Biol; 2001 Oct; 79(5):490-501. PubMed ID: 11564157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
    Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D
    Infect Immun; 2011 Apr; 79(4):1512-25. PubMed ID: 21300775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
    Barnes JL; Williams NL; Ketheesan N
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.
    Cuccui J; Easton A; Chu KK; Bancroft GJ; Oyston PC; Titball RW; Wren BW
    Infect Immun; 2007 Mar; 75(3):1186-95. PubMed ID: 17189432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.
    Müller CM; Conejero L; Spink N; Wand ME; Bancroft GJ; Titball RW
    Infect Immun; 2012 Sep; 80(9):3247-55. PubMed ID: 22778096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.